Preclinical rationale for combining radiation therapy and immunotherapy beyond checkpoint inhibitors (i.e., CART)

Translational Lung Cancer Research
James P FlynnSaumil J Gandhi

Abstract

An increasing appreciation for the role of the immune system in targeting cancer cells over the last decade has led to the development of several immunomodulatory agents aimed at enhancing the systemic antitumor immune response. One such method is the use of T cells that are genetically engineered to express chimeric antigen receptors (CARs). The remarkable success of this approach in advanced hematologic malignancies has garnered much enthusiasm for using this novel tool in treating other cancers. However, multiple challenges have hampered the application of this therapy to a broader set of solid tumors, most notably lung cancer. Immunotherapy has already shown great success in lung cancer, and is now the first-line treatment in PD-L1 expressing metastatic disease. Given the mounting evidence that radiation therapy plays a crucial role in amplifying the immune response elicited by immunomodulatory agents, there is potential for radiation to help in overcoming some of these challenges. In this review, we describe the basic principles of CAR T cell therapy and examine its successes and challenges to date. We then discuss the preclinical and clinical data supporting the use of radiation with immunomodulatory agents with a focus o...Continue Reading

Citations

Jan 16, 2019·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·O Leaman AlcibarM E Rodríguez-Ruiz
Nov 10, 2017·International Journal of Cancer. Journal International Du Cancer·Maria-Luisa SchubertMichael Schmitt
Nov 5, 2020·International Journal of Molecular Sciences·Sharda KumariAroumougame Asaithamby
Aug 6, 2019·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Edo Kon, Itai Benhar
Jan 16, 2021·The Urologic Clinics of North America·Sujit S NairAshutosh K Tewari
Jun 12, 2021·Frontiers in Neuroscience·Luke MaggsSoldano Ferrone
Nov 5, 2021·Expert Review of Anticancer Therapy·Lidia GattoAlba Ariela Brandes
Sep 17, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shwetha H ManjunathIma Paydar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Related Papers

Translational Research : the Journal of Laboratory and Clinical Medicine
Masha ZeltsmanPrasad S Adusumilli
Journal of Immunology Research
Hilde AlmåsbakMohan C Vemuri
Immunological Investigations
Thinle ChodonKunle Odunsi
© 2022 Meta ULC. All rights reserved